The certification, issued by TÜV SÜD Product Service GmbH, marks company to expand into globally regulated markets and reflects its adherence to international standards for safety, quality, and clinical performance.
Prognosys Medical Systems
develops digital imaging solutions, including fixed and mobile platforms aimed at improving diagnostic access across diverse healthcare settings. The development supports Molbio’s integrated diagnostics strategy by combining molecular diagnostics with radiological imaging to enable faster and more decentralised disease detection.